Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar

Adeel A. Butt (), Mylai D. Guerrero, Elenor B. Canlas, Husni Al-Dwairi, Abeir Bakhiet Mohammed Ali Alimam, Abdur Rehman Mohamad, Mohammed Thamer Ali, Nidal Ahmad Asaad, Ali Ahmed Sheikh Saleh Alkeldi, Mohammad Fawaz Saber Mohammad, Anil G. Thomas, Abdullatif Al-Khal, Muna Al-Maslamani and Abdul-Badi Abou-Samra
Additional contact information
Adeel A. Butt: Hamad Medical Corporation
Mylai D. Guerrero: Hamad Medical Corporation
Elenor B. Canlas: Hamad Medical Corporation
Husni Al-Dwairi: Hamad Medical Corporation
Abeir Bakhiet Mohammed Ali Alimam: Hamad Medical Corporation
Abdur Rehman Mohamad: Hamad Medical Corporation
Mohammed Thamer Ali: Hamad Medical Corporation
Nidal Ahmad Asaad: Hamad Medical Corporation
Ali Ahmed Sheikh Saleh Alkeldi: Hamad Medical Corporation
Mohammad Fawaz Saber Mohammad: Hamad Medical Corporation
Anil G. Thomas: Hamad Medical Corporation
Abdullatif Al-Khal: Hamad Medical Corporation
Muna Al-Maslamani: Hamad Medical Corporation
Abdul-Badi Abou-Samra: Hamad Medical Corporation

Nature Communications, 2023, vol. 14, issue 1, 1-5

Abstract: Abstract Accurate determination of mortality attributable to SARS-CoV-2 vaccination is critical in allaying concerns about their safety. We reviewed every death in Qatar that occurred within 30 days of any SARS-CoV-2 vaccine administration between January 1, 2021 and June 12, 2022. Probability of association with SARS-CoV-2 vaccination was determined by four independent trained reviewers using a modified WHO algorithm. Among 6,928,359 doses administered, 138 deaths occurred within 30 days of vaccination; eight had a high probability (1.15/1,000,000 doses), 15 had intermediate probability (2.38/1,000,000 doses), and 112 had low probability or no association with vaccination. The death rate among those with high probability of relationship to SARS-CoV-2 vaccination was 0.34/100,000 unique vaccine recipients, while death rate among those with either high or intermediate probability of relationship to SARS-CoV-2 vaccination was 0.98/100,000 unique vaccine recipients. In conclusion, deaths attributable to SARS-CoV-2 vaccination are extremely rare and lower than the overall crude mortality rate in Qatar.

Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-022-35653-z Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-022-35653-z

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-35653-z

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().